| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1025575188 |
| P356 | DOI | 10.1186/1297-9716-43-29 |
| P932 | PMC publication ID | 3410789 |
| P698 | PubMed publication ID | 22500859 |
| P5875 | ResearchGate publication ID | 224034688 |
| P50 | author | María Jesús Grillo | Q74214900 |
| Edgardo Moreno | Q96160450 | ||
| P2093 | author name string | Ignacio Moriyón | |
| José María Blasco | |||
| Jean Pierre Gorvel | |||
| P2860 | cites work | Efficacy of ciprofloxacin versus doxycycline as prophylaxis against experimental murine Brucella melitensis infection. | Q45980783 |
| Brucella requires a functional Type IV secretion system to elicit innate immune responses in mice | Q46060709 | ||
| Control methods and thresholds of acceptability for antibrucella vaccines | Q46472472 | ||
| Expression of heme oxygenase-1 is associated with abortion caused by Brucella abortus infection in pregnant mice | Q46577068 | ||
| Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs | Q46611875 | ||
| Evaluation of Brucella abortus S19 vaccine strains by bacteriological tests, molecular analysis of ery loci and virulence in BALB/c mice. | Q46635502 | ||
| Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep. | Q46957498 | ||
| Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis | Q47218005 | ||
| Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors | Q47756992 | ||
| Brucella abortus-associated meningitis in aborted bovine fetuses | Q48624619 | ||
| Is Brucella an enteric pathogen? | Q50057108 | ||
| Immunization with attenuated Salmonella typhimurium producing catalase in protection against gastric Helicobacter pylori infection in mice | Q50102189 | ||
| Resistance and susceptibility of mice to bacterial infection. IV. Functional specificity in natural resistance to facultative intracellular bacteria | Q50210566 | ||
| Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice. | Q51472420 | ||
| Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4. | Q52520303 | ||
| Delayed type hypersensitivity-associated disruption of splenic periarteriolar lymphatic sheaths coincides with temporary loss of IFN-gamma production and impaired eradication of bacteria in Brucella abortus-infected mice. | Q52549872 | ||
| Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. | Q53995072 | ||
| In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev 1 and Brucella abortus B19 vaccines. | Q54045248 | ||
| Immunization against Brucella infections: immune response of mice, guinea pigs, and Cynomolgus philipinensis to live and killed Brucella melitensis strain Rev. I administered by various methods. | Q54054057 | ||
| Persistence of Brucella abortus in the livers of T cell-deficient nude mice | Q54169103 | ||
| Brucella melitensis Rev. 1 living attenuated vaccine: Stability of markers, residual virulence and immunogenicity in mice | Q54287519 | ||
| Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. | Q54340852 | ||
| Resistance of Brucella abortus infected mice to intravenous or intraperitoneal Brucella reinfection. | Q54618718 | ||
| Using genomic data to unravel the root of the placental mammal phylogeny | Q24676217 | ||
| Interferon-gamma promotes abortion due to Brucella infection in pregnant mice | Q24799597 | ||
| Of mice and not men: differences between mouse and human immunology | Q28246229 | ||
| The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene | Q28589797 | ||
| Brucella microti sp. nov., isolated from the common vole Microtus arvalis | Q31143885 | ||
| Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection | Q33291121 | ||
| Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. | Q33312505 | ||
| Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1. | Q33319274 | ||
| The differential interaction of Brucella and ochrobactrum with innate immunity reveals traits related to the evolution of stealthy pathogens | Q33468439 | ||
| Integrating proteomic, transcriptional, and interactome data reveals hidden components of signaling and regulatory networks | Q33488155 | ||
| Endogenous gamma interferon mediates resistance to Brucella abortus infection | Q33615088 | ||
| Effect of early antibiotic treatment on the antibody response to cytoplasmic proteins of Brucella melitensis in mice | Q33637479 | ||
| Brucella melitensis: a nasty bug with hidden credentials for virulence | Q33896055 | ||
| Murine and bovine γδ T cells enhance innate immunity against Brucella abortus infections | Q33963886 | ||
| MyD88 and STING signaling pathways are required for IRF3-mediated IFN-β induction in response to Brucella abortus infection | Q33988738 | ||
| Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection | Q34009498 | ||
| Evaluation of the Sprague-Dawley rat as a model for vertical transmission of Brucella abortus. | Q34075750 | ||
| Macrophage activation during experimental murine brucellosis: a basis for chronic infection | Q34077663 | ||
| Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium | Q34160505 | ||
| Virulence criteria for Brucella abortus strains as determined by interferon regulatory factor 1-deficient mice | Q34257922 | ||
| Recall of Acquired Cellular Resistance in Mice by Antigens from Killed Brucella | Q34466936 | ||
| Lymphocyte proliferation in response to Brucella abortus 2308 or RB51 antigens in mice infected with strain 2308, RB51, or 19 | Q34542711 | ||
| Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. | Q34544752 | ||
| Nramp1 is not a major determinant in the control of Brucella melitensis infection in mice | Q34581384 | ||
| Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice | Q34721256 | ||
| Brucella abortus RB51 induces protection in mice orally infected with the virulent strain B. abortus 2308. | Q34932167 | ||
| Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion system, and lipopolysaccharide O antigen | Q34995443 | ||
| Pathology of striped dolphins (Stenella coeruleoalba) infected with Brucella ceti | Q35015626 | ||
| Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine | Q35073849 | ||
| Lipopolysaccharide-Deficient Brucella Variants Arise Spontaneously during Infection | Q35155281 | ||
| Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51. | Q35380623 | ||
| Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts | Q35393511 | ||
| Interleukin-10 downregulates protective immunity to Brucella abortus. | Q35396687 | ||
| Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. | Q35401154 | ||
| Lack of a role for natural killer cells in early control of Brucella abortus 2308 infections in mice | Q35444624 | ||
| Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms | Q35506571 | ||
| Rough vaccines in animal brucellosis: structural and genetic basis and present status. | Q35751808 | ||
| Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice | Q35758804 | ||
| Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis | Q35913680 | ||
| Kinetics of placental colonization of mice inoculated intravenously with Brucella abortus at day 15 of pregnancy | Q36090030 | ||
| Colonization of mouse placentas by Brucella abortus inoculated during pregnancy | Q36091441 | ||
| BvrR/BvrS-controlled outer membrane proteins Omp3a and Omp3b are not essential for Brucella abortus virulence | Q36097211 | ||
| Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge | Q36097216 | ||
| Development of structures and transport functions in the mouse placenta | Q36124326 | ||
| Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice | Q36228814 | ||
| Recruitment of dendritic cells to pathological niches in inflamed liver | Q36260655 | ||
| THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE | Q36266578 | ||
| Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection? | Q36752941 | ||
| Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export | Q36755736 | ||
| Effects of gamma interferon and indomethacin in preventing Brucella abortus infections in mice | Q36952833 | ||
| Protection against Brucella melitensis or Brucella abortus in mice with immunoglobulin G (IgG), IgA, and IgM monoclonal antibodies specific for a common epitope shared by the Brucella A and M smooth lipopolysaccharides | Q36954697 | ||
| Prophylaxis or treatment of experimental brucellosis with interleukin-1 | Q36963615 | ||
| Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum | Q36976243 | ||
| Influence of endotoxin-protein in immunoglobulin G isotype responses of mice to Brucella abortus lipopolysaccharide. | Q37013941 | ||
| Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice | Q37026362 | ||
| Induction of immune and adjuvant immunoglobulin G responses in mice by Brucella lipopolysaccharide | Q37037875 | ||
| The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle | Q37075414 | ||
| Immune serum-mediated effects on brucellosis evolution in mice | Q37108907 | ||
| Natural antibody contributes to host defense against an attenuated Brucella abortus virB mutant. | Q37256467 | ||
| Nondividing but metabolically active gamma-irradiated Brucella melitensis is protective against virulent B. melitensis challenge in mice | Q37410370 | ||
| Pathogenesis of bovine brucellosis. | Q37592524 | ||
| An evolutionary strategy for a stealthy intracellular Brucella pathogen | Q37846874 | ||
| Nucleotide-binding oligomerization domain-1 and -2 play no role in controlling Brucella abortus infection in mice | Q39725033 | ||
| Host susceptibility to Brucella abortus infection is more pronounced in IFN-γ knockout than IL-12/β2-microglobulin double-deficient mice | Q39802365 | ||
| Interleukin-1 receptor-associated kinase 4 is essential for initial host control of Brucella abortus infection | Q40315170 | ||
| Comparative study of gamma interferon production in mice immunized with outer membrane proteins and whole bacteria of Brucella abortus. | Q40368172 | ||
| Brucellosis in 418 patients from the Balkan Peninsula: exposure-related differences in clinical manifestations, laboratory test results, and therapy outcome. | Q40459551 | ||
| Brucella abortus nicotinamidase (PncA) contributes to its intracellular replication and infectivity in mice | Q40534167 | ||
| Resistance against a subcutaneous Brucella challenge of mice immunized with living or dead Brucella or by transfer of immune serum | Q41351852 | ||
| Genomic island 2 is an unstable genetic element contributing to Brucella lipopolysaccharide spontaneous smooth-to-rough dissociation | Q41430521 | ||
| Development and characterization of mouse models of infection with aerosolized Brucella melitensis and Brucella suis | Q41882903 | ||
| Mice lacking components of adaptive immunity show increased Brucella abortus virB mutant colonization | Q41960724 | ||
| Neurobrucellosis associated with syndrome of inappropriate antidiuretic hormone with resultant diabetes insipidus and hypothyroidism. | Q41992813 | ||
| CD8+ Type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I‐ and class II‐deficient mice | Q42479525 | ||
| OBSERVATIONS ON THE INFECTION OF CHICK EMBRYOS WITH BACTERIUM TULARENSE, BRUCELLA, AND PASTEURELLA PESTIS. | Q42812951 | ||
| Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria. | Q42909254 | ||
| A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice | Q42913659 | ||
| MyD88, but not toll-like receptors 4 and 2, is required for efficient clearance of Brucella abortus | Q42957064 | ||
| Role of TLRs in Brucella mediated murine DC activation in vitro and clearance of pulmonary infection in vivo | Q43230783 | ||
| Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infection. | Q43291542 | ||
| DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate | Q43433173 | ||
| T cell subsets in granulomatous inflammation and immunity to L. Monocytogenes and B. abortus | Q43677566 | ||
| Comparison of T cell cytokines in resistant and susceptible mice infected with virulent Brucella abortus strain 2308. | Q43749108 | ||
| Reactivation of a residual Brucella abortus 19 vaccine infection in mice by a virulent challenge or by injection of brucellin or of Brucella lipopolysaccharide. | Q43839947 | ||
| Experimental Studies with Four Species of Brucella in Selected Wildlife, Laboratory, and Domestic Animals *,† | Q43887127 | ||
| Endogenous gamma interferon and interleukin-10 in Brucella abortus 2308 infection in mice | Q44130650 | ||
| Efficacy of oral levofloxacin and dirithromycin alone and in combination with rifampicin in the treatment of experimental murine Brucella abortus infection | Q44794379 | ||
| IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses | Q44918119 | ||
| Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline | Q44948060 | ||
| Outcome and immune responses after Brucella abortus infection in young adult and aged mice | Q45070757 | ||
| Humoral immunity in mice mediated by monoclonal antibodies against the A and M antigens of Brucella | Q45079010 | ||
| Placental pathology of the pregnant mouse inoculated with Brucella abortus strain 2308. | Q45094191 | ||
| Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides | Q45251770 | ||
| The defect in the metabolism of erythritol of the Brucella abortus B19 vaccine strain is unrelated with its attenuated virulence in mice | Q45259196 | ||
| [Course of chronic brucellosis in mice is not improved by administration of a vaccinal antigen] | Q71646267 | ||
| Mother to young transmission of Brucella abortus infection in mouse model | Q71649152 | ||
| Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes | Q71932258 | ||
| Genetic factors involved in murine susceptibility to experimental brucellosis | Q72051029 | ||
| Brucella melitensis Rev-1 vaccine as a cause of human brucellosis | Q72231940 | ||
| Interleukin-6 production during chronic experimental infection | Q72568006 | ||
| BALB/c mice infected with Brucella abortus express protracted polyclonal responses of both IgG2a and IgG3 isotypes | Q72630533 | ||
| Therapeutic effects of rifampin and erythromycin in experimental murine brucellosis | Q73417690 | ||
| Frequent exposure of mice to crude Brucella abortus proteins down-regulates immune response | Q73600943 | ||
| Bacteriologic and histologic features in mice after intranasal inoculation of Brucella melitensis | Q73690481 | ||
| Growth of Brucella abortus in macrophages from resistant and susceptible mouse strains | Q74129593 | ||
| Studies in the pathology and pathogenesis of experimental brucellosis. II. The formation of the hepatic granuloma and its evolution | Q75802937 | ||
| Studies in the pathology and pathogenesis of experimental brucellosis. III. Investigations pertaining to the function of the spleen | Q75895028 | ||
| Immune control of Brucella abortus 2308 infections in BALB/c mice | Q77369300 | ||
| Brucellosis in Venezuela | Q78468241 | ||
| Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection | Q78468297 | ||
| Treatment of Brucella-susceptible mice with IL-12 increases primary and secondary immunity | Q79447326 | ||
| The behavior of Brucella neotomae and Brucella suis in reciprocal superinfection experiments in mice and guinea pigs | Q79647278 | ||
| Central role of MyD88-dependent dendritic cell maturation and proinflammatory cytokine production to control Brucella abortus infection | Q80455158 | ||
| A study on the use of male animal models for developing a live vaccine for brucellosis | Q81063069 | ||
| Temporal analysis of pathogenic events in virulent and avirulent Brucella melitensis infections | Q81192466 | ||
| Regulated upon activation normal T-cell expressed and secreted (RANTES) contributes to abortion caused by Brucella abortus infection in pregnant mice | Q81752341 | ||
| B cell-deficient mice display markedly enhanced resistance to the intracellular bacterium Brucella abortus | Q83750636 | ||
| Epidemiological study of Brucellosis in cattle, immunized with Brucella abortus RB51 vaccine in endemic zones | Q83982821 | ||
| CD4+CD25+ T regulatory cells limit effector T cells and favor the progression of brucellosis in BALB/c mice | Q56771725 | ||
| Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants | Q57040908 | ||
| Brucella abortus nicotinamidase (PncA) contributes to its intracellular replication and infectivity in mice | Q57360870 | ||
| Protective Action of Monospecific Anti-Brucella Sera in Mice | Q59027623 | ||
| Evaluation of particulate acellular vaccines against Brucella ovis infection in rams | Q59276365 | ||
| Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice | Q59276377 | ||
| MyD88-Dependent Activation of B220-CD11b+LY-6C+ Dendritic Cells during Brucella melitensis Infection | Q59312649 | ||
| Morphometric and Histopathologic Analysis of Lymphoid Depletion in Murine Spleens Following Infection with Brucella abortus strains 2308 or RB51 or an htrA Deletion Mutant | Q60121748 | ||
| Reduced interleukin-18 secretion in Brucella abortus 2308-infected murine peritoneal macrophages and in spleen cells obtained from B. abortus 2308-infected mice | Q61278515 | ||
| Differential secretion of interleukin-12 (IL-12) subunits and heterodimeric IL-12p70 protein by CD-1 mice and murine macrophages in response to intracellular infection by Brucella abortus | Q61278519 | ||
| Experimental bovine brucellosis. 3. The vaginal excretion of Brucella abortus before and after parturition | Q67247812 | ||
| Effect of polyadenine: polyuridine on brucellosis in conventional and congenitally athymic mice | Q67278960 | ||
| Polyadenylic acid-polyuridylic acid (poly A : U) and experimental murine brucellosis. I. Effect of single and double-stranded polynucleotides on Brucella abortus in vivo and in vitro | Q67367969 | ||
| Development of spleenic infection in the mouse following intravenous inoculation of various species of Brucella in smooth (S) or rough (R) phases | Q67512727 | ||
| Studies of some biological activities of "brucella" endotoxin in normal and infected animals and the role of the hypersensitivity factor | Q67683624 | ||
| [Transformatinon normalizing the distribution of the number of Brucella organisms in the spleen of rats vaccinated intraperitoneally] | Q67866388 | ||
| Immunogenicity of Brucella-extracted and recombinant protein vaccines in CD-1 and BALB/c mice | Q68354141 | ||
| Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice | Q68367993 | ||
| Comparative histopathology in BALB/c mice infected with virulent and attenuated strains of Brucella abortus | Q68370283 | ||
| Duration of strain 2308 infection and immunogenicity of Brucella abortus lipopolysaccharide in five strains of mice | Q69186013 | ||
| Immunologic, histopathologic, and bacteriologic responses of five strains of mice to Brucella abortus strain 2308 | Q69186019 | ||
| Clinical categories of neurobrucellosis. A report on 19 cases | Q69716388 | ||
| T cell regulation of the thymus-independent antibody response to trinitrophenylated-Brucella abortus (TNP-BA) | Q69860763 | ||
| Protection conferred on mice by monoclonal antibodies directed against outer-membrane-protein antigens of Brucella | Q70130424 | ||
| Pathogenesis of placentitis in the goat inoculated with Brucella abortus. I. Gross and histologic lesions | Q70296685 | ||
| Serum- and cell-mediated immune protection of mouse placenta and fetus against a Brucella abortus challenge: expression of barrier effect of placenta | Q70386323 | ||
| Some aspects of experimental bovine brucellosis | Q70390879 | ||
| Virulence of Brucella: bacterial growth and decline in mice | Q70398206 | ||
| Evaluation of vaccines and of antigen therapy in a mouse model for Brucella ovis | Q70545779 | ||
| [Development of Brucella abortus, Brucella melitensis and Brucella and Brucella suis infection infection in mice to a chronic stage and cure] | Q70585514 | ||
| [Proposed general method of controlling the activity of brucella vaccines] | Q70645216 | ||
| Theoretical, practical and statistical basis for a general control method of activity for anti-Brucella vaccines | Q70645220 | ||
| Effect of Brucella abortus transfer factor in preventing murine brucellosis | Q70838122 | ||
| Genetic factors involved in murine resistance to experimental brucellosis | Q70960853 | ||
| Antibiotic treatment induces an increase of the specific antibody levels in Brucella melitensis infected mice | Q70972698 | ||
| Penetration of antibiotics into human leukocytes and dermal suction blisters | Q71083842 | ||
| Inadequate azithromycin activity against Brucella melitensis in mice with acute or chronic infections | Q71601786 | ||
| Resistance and susceptibility of mice to bacterial infection. IV. Genetic and cellular basis of resistance to chronic infection with Brucella abortus | Q71615333 | ||
| In vivo and in vitro effects of monoclonal antibody to Ly antigens on immunity to infection | Q71628011 | ||
| Serological follow-up of human brucellosis by measuring IgG antibodies to lipopolysaccharide and cytoplasmic proteins of Brucella species | Q71644766 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brucellosis | Q156050 |
| Brucella | Q313358 | ||
| Mus | Q39275 | ||
| animal disease model | Q64732998 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 29 | |
| P577 | publication date | 2012-04-13 | |
| P1433 | published in | Veterinary Research | Q15761008 |
| P1476 | title | What have we learned from brucellosis in the mouse model? | |
| P478 | volume | 43 |
| Q59133593 | A Neglected Animal Model for a Neglected Disease: Guinea Pigs and the Search for an Improved Animal Model for Human Brucellosis |
| Q46276535 | Activation of NF-kB-Mediated TNF-Induced Antimicrobial Immunity Is Required for the Efficient Brucella abortus Clearance in RAW 264.7 Cells. |
| Q89981375 | Adenosine receptor Adora2b antagonism attenuates Brucella abortus 544 infection in professional phagocyte RAW 264.7 cells and BALB/c mice |
| Q89766067 | B cells Inhibit CD4+ T cell Mediated Immunity to Brucella Infection in a MHCII-Dependent Manner |
| Q40804991 | Bioluminescence Imaging of Colonization and Clearance Dynamics of Brucella Suis Vaccine Strain S2 in Mice and Guinea Pigs |
| Q41701210 | Brucella abortus S19 and RB51 vaccine immunogenicity test: Evaluation of three mice (BALB/c, Swiss and CD-1) and two challenge strains (544 and 2308). |
| Q28598240 | Brucella abortus Strain 2308 Wisconsin Genome: Importance of the Definition of Reference Strains |
| Q34056668 | Brucella abortus depends on pyruvate phosphate dikinase and malic enzyme but not on Fbp and GlpX fructose-1,6-bisphosphatases for full virulence in laboratory models. |
| Q40552706 | Brucella abortus ΔrpoE1 confers protective immunity against wild type challenge in a mouse model of brucellosis |
| Q36281386 | Brucella canis is an intracellular pathogen that induces a lower proinflammatory response than smooth zoonotic counterparts |
| Q38078458 | Brucella evasion of adaptive immunity |
| Q38841390 | Brucella melitensis and Mycobacterium tuberculosis depict overlapping gene expression patterns induced in infected THP-1 macrophages |
| Q46989352 | Brucella ovis lacking a species-specific putative ATP-binding cassette transporter is attenuated but immunogenic in rams |
| Q37704443 | Brucella spp. of amphibians comprise genomically diverse motile strains competent for replication in macrophages and survival in mammalian hosts |
| Q40887219 | Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections |
| Q38282517 | Brucella, nitrogen and virulence. |
| Q38794720 | Brucellosis vaccines for livestock |
| Q37492107 | COX-2 Inhibition Reduces Brucella Bacterial Burden in Draining Lymph Nodes. |
| Q90760962 | Cell mediated immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence strain Rev. 1 |
| Q35546587 | Cervical Lymph Nodes as a Selective Niche for Brucella during Oral Infections |
| Q92903745 | Characterization of Brucella canis infection in mice |
| Q57191762 | Characterization of Cell Envelope Multiple Mutants of and Assessment in Mice of Their Vaccine Potential |
| Q64064783 | Characterization of an intratracheal aerosol challenge model of Brucella melitensis in guinea pigs |
| Q90489394 | Chemokine receptor 4 (CXCR4) blockade enhances resistance to bacterial internalization in RAW264.7 cells and AMD3100, a CXCR4 antagonist, attenuates susceptibility to Brucella abortus 544 infection in a murine model |
| Q36396770 | Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice |
| Q34248432 | Deletion of the GI-2 integrase and the wbkA flanking transposase improves the stability of Brucella melitensis Rev 1 vaccine |
| Q40072449 | Development and trial of vaccines against Brucella |
| Q26750851 | Establishment of Chronic Infection: Brucella's Stealth Strategy |
| Q33755285 | Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection |
| Q52344256 | Evaluation of immune responses in mice and sheep inoculated with a live attenuated Brucella melitensis REV1 vaccine produced in bioreactor. |
| Q42701712 | Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1. |
| Q90399740 | Evaluation of the General Organization of Veterinary Services control program of animal brucellosis in Egypt: An outbreak investigation of brucellosis in buffalo |
| Q36077522 | Experimental Challenge of Atlantic Cod (Gadus morhua) with a Brucella pinnipedialis Strain from Hooded Seal (Cystophora cristata) |
| Q58107777 | GFP tagging of Brucella melitensis Rev1 allows the identification of vaccinated sheep |
| Q38110546 | Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis |
| Q49631097 | Identification of lptA, lpxE, and lpxO, Three Genes Involved in the Remodeling of Brucella Cell Envelope. |
| Q47284465 | Immunization of guinea pigs with Salmonella delivered anti-Brucella formulation reduces organs bacterial load and mitigates histopathological consequences of Brucella abortus 544 challenge |
| Q40716095 | Immunogenicity Analysis of a Novel Subunit Vaccine Candidate Molecule-Recombinant L7/L12 Ribosomal Protein of Brucella suis |
| Q35075320 | In vivo identification and characterization of CD4⁺ cytotoxic T cells induced by virulent Brucella abortus infection. |
| Q46255545 | Lipocalin 2 (Lcn2) interferes with iron uptake by Brucella abortus and dampens immunoregulation during infection of RAW 264.7 macrophages. |
| Q35950931 | Marine Mammal Brucella Reference Strains Are Attenuated in a BALB/c Mouse Model. |
| Q36192841 | Meta-Analysis and Advancement of Brucellosis Vaccinology. |
| Q55111157 | Meta-Analysis of the Changes of Peripheral Blood T Cell Subsets in Patients with Brucellosis. |
| Q40873592 | Methyl gallate limits infection in mice challenged with Brucella abortus while enhancing the inflammatory response |
| Q93020232 | Moonlighting of Haemophilus influenzae heme acquisition systems contributes to the host airway-pathogen interplay in a coordinated manner |
| Q39044190 | Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice |
| Q37002295 | N-Formyl-Perosamine Surface Homopolysaccharides Hinder the Recognition of Brucella abortus by Mouse Neutrophils |
| Q40082024 | NLRP12 negatively regulates proinflammatory cytokine production and host defense against Brucella abortus |
| Q38873739 | Nanocarriers for spleen targeting: anatomo-physiological considerations, formulation strategies and therapeutic potential |
| Q64097070 | Neutrophils Dampen Adaptive Immunity in Brucellosis |
| Q34607727 | Neutrophils exert a suppressive effect on Th1 responses to intracellular pathogen Brucella abortus |
| Q54260204 | Overexpression of Cu-Zn SOD in Brucella abortus suppresses bacterial intracellular replication via down-regulation of Sar1 activity. |
| Q91129598 | Partial protection induced by Salmonella based Brucella vaccine candidate in pregnant guinea pigs |
| Q55447712 | Pathological changes and bacteriological assessments in the urinary tract of pregnant goats experimentally infected with Brucella melitensis. |
| Q60920922 | Persistence of in the Bone Marrow of Infected Mice |
| Q49530036 | Perspectives and Outcomes of the Activity of a Reference Laboratory for Brucellosis |
| Q35592058 | Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in mice |
| Q92071496 | Proteomic Analysis of Membrane Blebs of Brucella abortus 2308 and RB51 and Their Evaluation as an Acellular Vaccine |
| Q33633918 | Retrospective and prospective perspectives on zoonotic brucellosis |
| Q92239482 | Route of Infection Strongly Impacts the Host-Pathogen Relationship |
| Q35830978 | Serological diagnostic potential of recombinant outer membrane proteins (rOMPs) from Brucella melitensis in mouse model using indirect enzyme-linked immunosorbent assay |
| Q96303491 | Shedding of Brucella melitensis happens through milk macrophages in the murine model of infection |
| Q40992619 | Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection. |
| Q36755110 | Structural Studies of Lipopolysaccharide-defective Mutants from Brucella melitensis Identify a Core Oligosaccharide Critical in Virulence. |
| Q53406266 | The Fast-Growing Brucella suis Biovar 5 Depends on Phosphoenolpyruvate Carboxykinase and Pyruvate Phosphate Dikinase but Not on Fbp and GlpX Fructose-1,6-Bisphosphatases or Isocitrate Lyase for Full Virulence in Laboratory Models. |
| Q98771933 | The Three Flagellar Loci of Brucella ovis PA Are Dispensable for Virulence in Cellular Models and Mice |
| Q45091061 | The ferrous iron transporter FtrABCD is required for the virulence of Brucella abortus 2308 in mice |
| Q42227511 | The new strains Brucella inopinata BO1 and Brucella species 83-210 behave biologically like classic infectious Brucella species and cause death in murine models of infection. |
| Q41604807 | The protoxin Cry1Ac of Bacillus thuringiensis improves the protection conferred by intranasal immunization with Brucella abortus RB51 in a mouse model. |
| Q36970860 | Toll-like receptor 4-linked Janus kinase 2 signaling contributes to internalization of Brucella abortus by macrophages |
| Q46798276 | Utilization of host polyamines in alternatively activated macrophages promotes chronic infection by Brucella abortus |
| Q90139268 | Vaccine safety studies of Brucella abortus S19 and S19ΔvjbR in pregnant swine |
| Q36878415 | WrpA Is an Atypical Flavodoxin Family Protein under Regulatory Control of the Brucella abortus General Stress Response System. |
| Q58103382 | recapitulates attributes of zoonotic human disease in a murine infection model |
Search more.